Stoke Therapeutics, Inc. ($STOK)
Filing Information
| Accession Number | 0001762572-26-000006 |
|---|---|
| Form Type | 4 |
| Filing Date | Mar 19, 2026 |
| Document | View SEC Filing |
Transactions
5
Total Shares
3,712
Total Value
$119,310.80
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Patient Officer | Common Stock | โ | Mar 17, 2026 | Sale | 1,033 | $32.74 | $33,819.80 | 12,955 | Direct | โ | View Details | |
Chief Patient Officer | Common Stock | โ | Mar 17, 2026 | Sale | 748 | $33.38 | $24,964.80 | 12,207 | Direct | โ | View Details | |
Chief Patient Officer | Common Stock | โ | Mar 18, 2026 | Sale | 1,762 | $31.28 | $55,122.06 | 10,445 | Direct | โ | View Details | |
Chief Patient Officer | Common Stock | โ | Mar 18, 2026 | Sale | 139 | $31.79 | $4,418.64 | 10,306 | Direct | โ | View Details | |
Chief Patient Officer | Common Stock | โ | Mar 18, 2026 | Sale | 30 | $32.85 | $985.50 | 10,276 | Direct | โ | View Details |